DEBUG: PAGE=domain, TITLE=F&A & Supply Chain Transformation,ID=464,TEMPLATE=program
toggle expanded view
programcode = FSC
programid = 105
database = t
alerts = t
neat = t
vendors = t
forecasting = t
confidence = f
definitions = t

Search within: F&A & Supply Chain Transformation:

advanced options..

Access our analyst expertise:

Only NelsonHall clients who are logged in have access to our analysts and advisors for their expert advice and opinion.

To find out more about how NelsonHall's analysts and sourcing advisors can assist you with your strategy and engagements, please contact our sales department here.

Subscribe to blogs & alerts:

manage email alerts using the form below, in order to be notified via email whenever we publish new content:

has Database = t

Contracts Database

for F&A & Supply Chain Transformation

Track the pattern of service adoption by monitoring F&A & Supply Chain Transformation contract awards by your peers. Identify who are the successful vendors this industry now. Updated monthly!

These documents are available to logged in clients that have purchased access to this program.

has Confidence = f -- IGNORED

Rachael Stormonth on Latest Trends in F&A BPS

Rachael Stormonth, Senior Vice President at BPS analyst house NelsonHall, discusses the latest business trends in F&A BPS with Professional Outsourcing magazine, and describes how some companies are using it as a platform for business transformation.

Enhancing Supply Chain Resilience – Pharmaceuticals

Market Reports

by Vaibhav Wardhan

published on Oct 18, 2024

Access to this report is restricted to logged in clients with access. Login to get full access

Report Overview:

This report is an analysis of the results from a survey of 107 pharmaceuticals enterprises carried out by NelsonHall.

Who is this Report for:

NelsonHall’s “Enhancing Supply Chain Resilience – Pharmaceuticals” report assists organizations in understanding the supply chain process improvement requirements and initiatives to enhance the supply chain resilience of the pharmaceuticals sector.

This report is an analysis of the results from a survey of 107 pharmaceuticals enterprises carried out by NelsonHall.

The report is designed for:

  • CXOs within the pharmaceuticals sector looking to understand the enhancements required to improve supply chain resilience within their sector
  • Vendor marketing, sales, and business managers wishing to identify the initiatives with the greatest impact on resilience within the pharmaceuticals sector
  • Financial analysts and investors specializing in the services sector who are looking to understand the supply chain resilience pressures and initiatives within the pharmaceuticals sector.

Scope of this Report:

The report analyzes the enhancements required to enhance supply chain resilience in the pharmaceuticals sector and covers:

  • Key areas targeted for process improvement in the next two years
  • Opportunities for AI enhancement within supply chain management
  • Adequacy of existing supply chain information flows to meet future supply chain resilience needs
  • Enhancements required to improve supply chain resilience
  • Key characteristics for achieving a highly resilient supply chain
  • Areas where GenAI will have the greatest impact on supply chain resilience
  • The role of vendors in resilience initiatives.

The sectors covered in this series include:

  • Aerospace
  • Agriculture
  • Automotive
  • CPG
  • Energy
  • Food manufacturing
  • Healthcare Services
  • High-tech
  • Industrial manufacturing
  • Pharmaceuticals
  • Retail
  • Utilities.

The regions covered include:

  • U.S.
  • Europe
  • APAC
  • LATAM.

Key Findings & Highlights:

NelsonHall’s analysis of Supply Chain Resilience Enhancement within Pharmaceuticals enterprises consists of 23 pages. The report identifies that:

  • 82% of pharmaceuticals companies are targeting demand forecasting for process improvement in the next 2 years
  • 82% of pharmaceuticals companies believe increased competitiveness is a highly important objective from use of AI, but less than a seventh are already using AI to make them more competitive
  • 69% of pharmaceuticals companies believe there is a big opportunity for AI enhancement of production in the next 2 years.

This report is one of a series of detailed individual sector reports on enhancing supply chain resilience published by NelsonHall.

Login to get full access:

   register | forgot password ?
close